InMatrico® | Decellularized Extracellular Matrix (dECM) Kits
InMatrico® provides tissue-specific decellularized extracellular matrix technologies for physiologically relevant disease modeling, translational research, and therapeutic development.
Technology
Tissue-specific decellularized ECMs
Predictive results consistent with patient biology. TissueSpec® technologies support disease modeling and drug testing by providing tissue-specific biochemical and mechanical extracellular matrix signals often absent in conventional in vitro systems.
Primary tissues
Tissues are comprised of cells attached to ECM.
Tissue-specific dECMs
Tissue decellularization (cell removal) yields tissue-specific decellularized ECM (dECM).
TissueSpec® dECM Kits
Decellularized ECM (dECM) is processed into dECM coating and hydrogel kits.
Primary tissues are decellularized using proprietary protocols to obtain tissue-specific decellularized ECMs (dECM), which are then processed into quality-controlled, ready-to-use TissueSpec® dECM Coating and Hydrogel Kits.
International Distributors
United States
EU – Germany
EU -Switzerland
EU – Finland
EU – Sweden
EU – Austria
EU – Slovenia
EU – Portugal
EU – Hungary
EU – Denmark
EU – Croatia
EU – Spain
EU – Slovakia
EU – France
EU – Czech Republic
EU – Romania
EU – Bulgaria
EU – Greece
EU – Poland
EU – Cuprus
EU – Latvia
EU – Estonia
EU – Ireland
EU – Finland
Canada
EU – Netherlands
EU – Lithuania
EU – Belgium
EU – Italy
Japan
China & Hong Kong
South Korea
Singapore
India
Malaysia
